NAYA NAYA Biosciences Quarterly Revenue Growth

Public company logo of NAYA Biosciences Inc. (NAYA)

NAYA Biosciences is currently integrating assets following the merger, focusing on preclinical stages and the search for partners. Long-term patents form the business foundation, ensuring a future monopoly. The company's quarterly revenue growth demonstrates current dynamics, where 479.00 represents the current metric level. Development relies on the Flex-NK platform to create low-toxicity drugs targeting solid tumors.

NAYA Biosciences Inc (NAYA) - Quarterly Revenue Increase from 07/04/2022 to 04/28/2025

Metric breakdowns and analytics for NAYA Biosciences Inc (NAYA)

Basic company analysis:NAYA - nayabiosciences.com
Manufactured products of NAYA Biosciences Inc.

For the young biotech NAYA (NAYA), which focuses on preclinical oncology platforms without external expansion, quarterly sales growth serves as an indicator of the monetization efficiency of current assets. This metric captures the percentage change in revenue per quarter, allowing investors to assess cash flow dynamics and compare revenue growth rates with the stock price to identify if the asset is overbought.

Competitors of NAYA Biosciences

BeiGene Oncology - Quarterly Revenue Growth|HALO: Revenue Growth QoQ|Revolution Medicines Corp (RVMD) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Ascentage Pharma Group International (AAPG)|Revenue Growth QoQ CG Oncology, Inc.|Quarterly Revenue Growth Rate UroGen Pharma Corp URGN|Quarterly Revenue Growth BCAX|Personalis, Inc. - Sales Growth QoQ|Erasca - Quarterly Sales Growth|Quarterly Revenue Increase DCTH|YMAB: Quarterly Sales Growth|Quarterly Revenue Growth Rate Aura Corp|CADL: Quarterly Revenue Growth|ARAY - Quarterly Sales Growth Rate|SLS (SELLAS Life Sciences Group, Inc.) - Quarterly Revenue Growth|ACTU: Quarterly Revenue Increase|Revenue Growth QoQ citiusonc.com (CTOR)|Quarterly Sales Growth Rate TuHURA Biosciences|Revenue Growth QoQ Protara Therapeutics TARA|Fate Therapeutics (FATE) - Quarterly Revenue Growth Rate|WHWK - Revenue Growth QoQ|Quarterly Revenue Growth Rate TScan Therapeutics Inc|championsoncology.com (CSBR) - Revenue Growth QoQ|Sales Growth QoQ XBIT|Quarterly Sales Growth CVM|Sales Growth QoQ OSTX (OS Therapies Incorporated)|Quarterly Revenue Growth RADX|ARTV: Revenue Dynamics QoQ|Quarterly Revenue Growth ANL (Adlai Nortye Ltd)|VERU - Quarterly Sales Growth|tempesttx.com - Quarterly Revenue Growth|Quarterly Revenue Increase XLO (xiliotx.com)|RENB: Quarterly Revenue Growth|Quarterly Sales Growth Mural Oncology plc|Revenue Growth QoQ Kairos Pharma Inc|OKUR: Quarterly Revenue Increase|Quarterly Revenue Growth GDTC|CRIS (Curis) - Quarterly Revenue Increase|Revenue Growth QoQ apollomicsinc.com APLM|THAR: Sales Growth QoQ|advanbiomed.com - Quarterly Revenue Growth|Quarterly Revenue Increase GNPX (Genprex, Inc)|Calidi Biotherapeutics Inc. (CLDI) - Revenue Growth QoQ|Sunshine Biopharma Inc. (SBFM) - Quarterly Revenue Growth|XBIO (Xenetic Bio) - Quarterly Revenue Growth|Salarius Pharmaceuticals Inc (SLRX) - Quarterly Sales Growth Rate|Quarterly Revenue Growth PPBT|Quarterly Revenue Growth American Oncology Network Inc (AONC)|Quarterly Revenue Growth BGNE (BeiGene Ltd.)|Sales Change QoQ CKPT (Checkpoint Therapeutics)|ELEV - Revenue Growth QoQ|ICAD (iCAD Inc.) - Sales Growth QoQ|Ikena (IKNA) - Revenue Growth QoQ|Quarterly Sales Growth Notable Labs, Ltd.|Revenue Growth QoQ viracta.com|MOR: Quarterly Revenue Increase|Revenue Growth QoQ Ascentage Pharma Group Ltd (AAPGV)